Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

• Main Authors: Hui Yang (Author), Hang Yang (Author), Lixia Wang (Author), Honggang Shi (Author), Bojia Liu (Author), Xue Lin (Author), Qingyong Chang (Author), Jiande D. Z. Chen (Author), Zhijun Duan (Author)
• Format: Book
• Published: BMC, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background At present, ursodeoxycholic acid (UDCA) is internationally recognized as a therapeutic drug in clinic. However, about 40% Primary Biliary Cholangitis (PBC) patients are poor responders to UDCA. It has been demonstrated that Transcutaneous Neuromodulation (TN) can be involved in g...